To this day, the Company’s R&D team maintains continuous communication with frontline physicians, enabling timely identification of medical staff and patient needs. This ensures the Company’s products facilitate surgeons’ operative procedures and improve surgical success rates for patients.

The Company currently holds 123 authorized patents, comprising 117 domestic patents and 6 overseas patents. By patent type, there are 34 invention patents (including one Australian standard patent), 45 utility model patents, and 44 design patents.

Domestically, the Company’s distribution network covers nearly 30 provinces, autonomous regions and municipalities directly under the Central Government, including Zhejiang, Beijing, Guangdong, Shanghai and Jiangsu. Internationally, its client base spans the Americas, Europe, Asia, Oceania and other regions.